Rare blood diseases affect millions of people, yet few companies work on them because each disease is small on its own. Marrow Labs builds tools that let one team study many at once.

We invested at seed and introduced the team to the clinicians who became their first partners.

Marrow is now running research programmes with three European hospitals.